| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.058 | 0.3 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.3 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |